Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

NCT03739853 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Methotrexate
DRUG: Sulfasalazine
DRUG: Leflunomide
DRUG: Adalimumab

Sponsor

University of Oxford